Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 10 years
- Director since
- 2023
10 years of board service in total across 3 boards, counting each seat separately. Longest: Nurix Therapeutics Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Enliven Therapeutics Inc. June 9, 202664.7%
-
Oric Pharmaceuticals Inc. June 12, 202499.0%
-
Nurix Therapeutics Inc. May 4, 202387.5%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 30, 2026 | Enliven Therapeutics Inc. | Option exercise | +3,741 | $1.12 | $4,190 |
| Oct 30, 2026 | Enliven Therapeutics Inc. | Option exercise | +7,300 | $18.30 | $133,590 |
| Jul 6, 2026 | Enliven Therapeutics Inc. | Open-market sale | −4,111 | $49.98 | $205,468 |
| Jul 6, 2026 | Enliven Therapeutics Inc. | Open-market sale | −5,889 | $50.84 | $299,397 |
| Jun 5, 2026 | Enliven Therapeutics Inc. | Open-market sale | −7,779 | $34.28 | $266,664 |
| Jun 5, 2026 | Enliven Therapeutics Inc. | Open-market sale | −1,867 | $35.36 | $66,017 |
| Jun 5, 2026 | Enliven Therapeutics Inc. | Open-market sale | −354 | $35.82 | $12,680 |
| Dec 17, 2025 | Enliven Therapeutics Inc. | Option exercise | +15,958 | $1.12 | $17,873 |
| Dec 8, 2025 | Oric Pharmaceuticals Inc. | Option exercise | +10,000 | $7.90 | $79,000 |
| Dec 4, 2025 | Oric Pharmaceuticals Inc. | Option exercise | +5,534 | $3.75 | $20,753 |
| Mar 3, 2025 | Oric Pharmaceuticals Inc. | Option exercise | +27,666 | $3.75 | $103,748 |
| Mar 3, 2025 | Oric Pharmaceuticals Inc. | Option exercise | +20,500 | $6.33 | $129,765 |
| Jul 17, 2024 | Nurix Therapeutics Inc. | Gift | −54,027 | — | — |
| Jun 3, 2024 | Oric Pharmaceuticals Inc. | Option exercise | +20,500 | $3.75 | $76,875 |
Questions about Lori Anne Kunkel
What boards is Lori Anne Kunkel on?
Lori Anne Kunkel sits on the boards of Enliven Therapeutics Inc., Nurix Therapeutics Inc. and Oric Pharmaceuticals Inc.
How long has Lori Anne Kunkel served on boards?
Our records show at least 10 years of board service across 3 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.